HealthPhoto: Deccan HeraldNucelion and Pandorum Collaborate on Two Eye Therapy Projects
Hyderabad-based Nucelion Therapeutics, a subsidiary of Bharat Biotech, and Bengaluru's Pandorum Technologies have partnered to advance two ophthalmology projects supported by PRIP. The projects target therapies for advanced keratopathy and wet age-related macular degeneration. Pandorum is developing cell-free regenerative medicines using designer exosomes to address inflammation, fibrosis, and vascular issues while promoting tissue repair.
Deccan Herald·

